Cargando…

MrgX2-mediated internalization of LL-37 and degranulation of human LAD2 mast cells

LL-37 is the sole antimicrobial peptide of human cathelicidin comprising 37 amino acids, which is expressed mainly in epithelial cells and neutrophils, and activates mast cells. In the present study, in order to elucidate the mechanism of mast cell activation by LL-37, the associations between the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Taisuke, Suzuki, Kaori, Niyonsaba, Francois, Tada, Hiroyuki, Reich, Johannes, Tamura, Hiroshi, Nagaoka, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236315/ https://www.ncbi.nlm.nih.gov/pubmed/30280189 http://dx.doi.org/10.3892/mmr.2018.9532

Ejemplares similares

MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo‐allergic and anaphylactoid reactions
por: Grimes, Jak, et al.
Publicado: (2019)

A novel ELISA method to determine human MrgX2 in chronic urticaria
por: Ding, Yuanyuan, et al.
Publicado: (2020)

Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism
por: Hu, Zhongshuang, et al.
Publicado: (2014)

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
por: Nagaoka, Isao, et al.
Publicado: (2020)

Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils
por: Kumagai, Yumi, et al.
Publicado: (2020)

Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2)
por: Mullol, Joaquim, et al.
Publicado: (2013)

Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-κB p65 phosphorylation in senescent endothelial cells
por: Suzuki, Kaori, et al.
Publicado: (2019)

PACAP-38 and PACAP(6–38) Degranulate Rat Meningeal Mast Cells via the Orphan MrgB(3)-Receptor
por: Pedersen, Sara Hougaard, et al.
Publicado: (2019)

Differential Expression of Gene Profiles in MRGX-treated Lung Cancer
por: Kwon, Yong-Kyun, et al.
Publicado: (2013)

Modulation of Neutrophil Apoptosis by Antimicrobial Peptides
por: Nagaoka, Isao, et al.
Publicado: (2012)

Mast cell degranulation is negatively regulated by the Munc13-4-binding small-guanosine triphosphatase Rab37
por: Higashio, Hironori, et al.
Publicado: (2016)

SNARE complex-mediated degranulation in mast cells
por: Woska, Joseph R, et al.
Publicado: (2012)

Purinergic Signaling in Mast Cell Degranulation and Asthma
por: Gao, Zhan-Guo, et al.
Publicado: (2017)

Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells
por: Agier, Justyna, et al.
Publicado: (2018)

Degranulation of human mast cells: modulation by P2 receptors’ agonists
por: Schulman, Edward S., et al.
Publicado: (2023)

Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium
por: Grace, Shane A, et al.
Publicado: (2017)

The RLR/NLR expression and pro-inflammatory activity of tissue mast cells are regulated by cathelicidin LL-37 and defensin hBD-2
por: Agier, Justyna, et al.
Publicado: (2018)

Involvement of Hypoxia-Inducible Factor-1 in the Inflammatory Responses of Human LAD2 Mast Cells and Basophils
por: Sumbayev, Vadim V., et al.
Publicado: (2012)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis
por: Klein, Ofir, et al.
Publicado: (2019)

Increased Mast Cell Counts and Degranulation in Microscopic Colitis
por: Chi, Zhikai, et al.
Publicado: (2020)

Degranulation of Mast Cells as a Target for Drug Development
por: Yang, Bo-Gie, et al.
Publicado: (2023)

P2X7 receptors induce degranulation in human mast cells
por: Wareham, Kathryn J., et al.
Publicado: (2016)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2
por: Yao, Ciyu, et al.
Publicado: (2023)

Inhibition of NO-synthase and degranulation of rat omental mast cells in vitro
por: Northover, A. M., et al.
Publicado: (1996)

EFFECT OF LEUCAS ASPERA ON EXPERIMENTAL INFLAMMATION AND MAST CELL DEGRANULATION
por: Reddy, M. Kannappa, et al.
Publicado: (1986)

Effect of fruits of Opuntia elatior Mill on mast cell degranulation
por: Chauhan, Sanjay P., et al.
Publicado: (2015)

Contribution of engineered nanomaterials physicochemical properties to mast cell degranulation
por: Johnson, Monica M., et al.
Publicado: (2017)

The effect of laparoscopy on mast cell degranulation and mesothelium thickness in rats
por: Poerwosusanta, Hery, et al.
Publicado: (2020)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Co-Stimulation of Purinergic P2X4 and Prostanoid EP3 Receptors Triggers Synergistic Degranulation in Murine Mast Cells
por: Yoshida, Kazuki, et al.
Publicado: (2019)

Degranulation of individual mast cells in response to Ca2+ and guanine nucleotides: an all-or-none event
Publicado: (1993)

Authentic and Ectopically Expressed MRGPRX2 Elicit Similar Mechanisms to Stimulate Degranulation of Mast Cells
por: Lazki-Hagenbach, Pia, et al.
Publicado: (2021)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e127lapj7909jgr6p0guihk8oo